Loading
Latest filing published 19 Feb 2021 for NexImmune, Inc..
No signal scores available.
Only one filing by Scott Carmer is known so far (19 February 2021): a transaction, in NexImmune, Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration